Masato Onozaki
Masato Onozaki publishes mostly in Surgery, Oncology and Pulmonary and Respiratory Medicine, on topics such as Neuroendocrine Tumor Research Advances, Urinary and Genital Oncology Studies and Pancreatic and Hepatic Oncology Research.
- World rank
- #6,826,049 of 7,710,434 ranked researchers
- Rank in Japan
- #291,109 of 383,136
- Works
- 19
- Citations
- 85
- Citations per work
- 4.5
What does Masato Onozaki research?
Masato Onozaki's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (9%), Health Professions (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences1156.2%
- Medicine949.2%
- Health Professions17.0%
- Everything else735.0%
- Life Sciences28.8%
- 1Surgery21% of their works
- 2Oncology12% of their works
- 3Pulmonary and Respiratory Medicine9% of their works
- 4Molecular Biology9% of their works
- 5General Health Professions7% of their works
- 6Epidemiology7% of their works
Research topics
- Neuroendocrine Tumor Research Advances
- Urinary and Genital Oncology Studies
- Pancreatic and Hepatic Oncology Research
- Bladder and Urothelial Cancer Treatments
- Interprofessional Education and Collaboration
- Gastrointestinal Tumor Research and Treatment
- Lung Cancer Research Studies
- Lymphoma Diagnosis and Treatment
Which keywords describe Masato Onozaki's research?
The keywords of their largest research topics: Chemotherapy, Immunotherapy, Neoadjuvant Therapy, Neuroendocrine Tumors, Pancreatic Neuroendocrine Tumors, PET Imaging, Primary Urethral Carcinoma and Prognostic Factors.
- Sunitinib
- Lymphoma
- Imatinib Mesylate
- Classification
- Surgical Complications
- Bladder Cancer
- Prognostic Factors
- Pancreatic Neuroendocrine Tumors
- Neuroendocrine Tumors
- Immunotherapy
- Chemotherapy
- Neoadjuvant Therapy
- PET Imaging
- Primary Urethral Carcinoma
- Urachal Carcinoma
- Pancreatic Cancer
- Urothelial Carcinoma
- Genomic Profiles
- Interprofessional Education
- Small-Cell Lung Cancer
- Teamwork
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.
All 21 words, with their numbers
- Chemotherapy83 topics
- Immunotherapy83 topics
- Neoadjuvant Therapy62 topics
- Neuroendocrine Tumors41 topic
- PET Imaging42 topics
- Pancreatic Neuroendocrine Tumors41 topic
- Primary Urethral Carcinoma41 topic
- Prognostic Factors42 topics
- Urachal Carcinoma41 topic
- Bladder Cancer31 topic
- Pancreatic Cancer31 topic
- Surgical Complications31 topic
- Urothelial Carcinoma31 topic
- Classification21 topic
- Genomic Profiles21 topic
- Imatinib Mesylate21 topic
- Interprofessional Education21 topic
- Lymphoma21 topic
- Small-Cell Lung Cancer21 topic
- Sunitinib21 topic
- Teamwork21 topic
Where does Masato Onozaki work?
Masato Onozaki's main affiliation in the publication record is Dokkyo Medical University, Japan.
How many publications and citations does Masato Onozaki have?
OpenAlex counts 19 works and 85 citations for Masato Onozaki, an h-index of 5, ranking #6,826,049 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Masato Onozaki. Posts are plain text and can be reported.